What is kava? Major warnings issued on TikTok about ‘Feel Free' drinks amid kratom products ban in Louisiana
This comes as FDA warns that products made from kratom, a plant found in Southeast Asia, are becoming more common in gas stations, corner stores, and vape shops countrywide.
The drug is frequently used to 'self-treat conditions such as pain, coughing, diarrhea, anxiety and depression, opioid use disorder, and opioid withdrawal,' the FDA stated.
University of Minnesota Medical School addiction medicine specialist Dr. Robert Levy told NBC News that he has "many times" handled patients who became addicted to kratom.
Also Read: Kratom rise sparks concerns over addiction amid RFK Jr's 7-OH crackdown; What is it and how it impacts your health
What is kava or kratom?
Although kava and/or kratom-based drinks have been promoted as mood enhancers and energy boosters, some customers claim that the items are causing addiction.
If kava is used frequently to treat anxiety, stress, or sleep issues, people may become psychologically dependent on it. According to Crestview Recovery, this might result in increased tolerance, minor withdrawal symptoms, compulsive usage, responsibility neglect, and trouble cutting back on use.
Warnings spread on TikTok about 'Feel Free' drinks
Last month, TikToker Misha Brown shared a video that went viral, showing how a child approached him at a petrol station and requested him to buy a Feel Free tonic, a kratom-containing beverage. Brown claimed that after he declined, the boy attempted to take his wallet but was unsuccessful in his attempt.
The clerk at the gas station then informed Brown that she frequently witnesses the same consumers purchasing the same beverage several times throughout the day. 'It's so addictive, and people lose their minds,' Brown claimed the cashier informed him.
Speaking about the viral video, Brown told NBC News, individuals started sharing their own 'devastating experiences' after using kratom products like Feel Free.
John, a TikToker who has shared content on Feel Free after battling with heroin and meth addictions, claimed to have found the tonic when he was eight years sober.
NBC News John in a bid to preserve his identity.
John admitted to the source that he developed an addiction and started devouring entire Feel Free cases in a single day.
In February, he was admitted to the hospital for severe withdrawal symptoms as he attempted to stop using Feel Free.
Feel Free tonics are supplied in two-ounce containers. A serving size is one ounce, according to the label, and consumers should not take more than two ounces in a 24-hour period, according to NBC News. In addition, the label cautions that the product can lead to habit formation and suggests that people who have previously abused substances should think twice before using it.
Here's what Botanic Tonics said
Botanic Tonics, the company that produces Feel Free, said in a statement to The Independent that the NBC News piece featured "false and misleading statements" and that they had not received any complaints about serious addiction.
Earlier, Botanic Tonics settled a class action lawsuit alleging the firm failed to alert users about the risks of kratom in 2023 for $8.75 million. The company settled the claim without acknowledging any wrongdoing.
Ban on kratom products in Louisiana. Are items made from kava prohibited in the state?
The Louisiana House of Representatives approved Senate Bill 154 (SB154), which would outlaw the distribution and possession of kratom.
The House cleared SB154 by a vote of 87 to 6. Since the Senate has already approved the bill, it now needs to be signed into law by Governor Jeff Landry.
SB154 would designate mitragynine and 7-hydroxymitragynine as Schedule 1 drugs, which are chemicals that are currently not approved for use in medicine in the United States and are thought to have a high potential for misuse. According to the bill, it would also make it illegal to produce, distribute, or possess kratom.
Although Louisiana has implemented laws pertaining to the distribution and possession of kratom, the state has not outlawed the sale of kava products. Nonetheless, several parishes have imposed local prohibitions, and state-level rules have been put into effect.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 hours ago
- Time of India
How a one-minute jolt from the SetPoint implant offers new hope for autoimmune disease patients
The US Food and Drug Administration (FDA) recently approved a medical device that could bring new hope to patients suffering from rheumatoid arthritis (RA), a chronic autoimmune condition often difficult to treat with conventional medications. Unlike standard therapies, the device harnesses the brain and nervous system to suppress the uncontrolled inflammation responsible for the disease. The SetPoint System is a small, inch-long implant surgically placed in the neck, wrapping around the vagus nerve, which is thought to be the longest nerve in the body. It delivers one minute of electrical stimulation per day, which research suggests can 'reset' the immune system and reduce crippling inflammation. Unlike most RA drugs that suppress the immune system and increase infection risk, this device works by re-educating the body's immune response. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Described on a recent episode of the American College of Rheumatology podcast as a 'true paradigm shift' in RA treatment, the SetPoint implant moves away from decades of reliance on pharmaceuticals, from gold salts to biologics. The FDA had granted it breakthrough designation last year to accelerate development and approval. The device represents an early example of bioelectronic medicine, which aims to control inflammation—a key factor in conditions including diabetes, heart disease, and cancer. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Clinical trials are already exploring vagus nerve stimulation for inflammatory bowel disease in children, lupus, multiple sclerosis, and Crohn's disease. In a yearlong randomized controlled trial involving 242 patients with a sham-treatment group, over half of participants using the implant alone achieved remission or experienced disease improvement. Joint pain and swelling decreased by 60% and 63%, respectively. However, the device's long-term safety and effectiveness outside clinical trials remain unknown, and the FDA requires post-marketing monitoring. Experts warn that surgery for implants can carry a risk of serious infections resistant to antibiotics. For Dawn Steiner, a 58-year-old speech pathologist and clinical trial participant, the implant has been transformative. Diagnosed with RA 15 years ago, she tried eight biologic drugs with limited success. 'Before the implant, the doctor would ask where I was in terms of pain on a scale of one to 10, and I would say I was living a six or seven,' she said. 'Now I'm about a two.' Live Events The SetPoint device stems from decades of research led by Dr. Kevin J. Tracey, neurosurgeon and president of the Feinstein Institutes for Medical Research at Northwell Health. Tracey co-founded SetPoint Medical and now serves as an adviser. He describes the vagus nerve as an 'on-off switch' for an overactive immune system. 'The brain can turn off inflammation as long as the vagus nerve is intact,' he said. 'It's like a brake system in your car.' Dr. David Chernoff, chief medical officer of SetPoint Medical, explained, 'Drugs find a pathway that contributes to damaging joints in RA patients and try to block it. What we're doing is completely different. We're re-educating the immune system through the brain to behave differently.' He added, 'we're not blocking the ability to fight off infection.' Tracey noted that some inflammation is necessary for healing wounds, fighting infections, and tissue repair. The device's price has not been disclosed, but a spokeswoman said it is designed to last 10 years and could cost less than a year of certain RA medications. Dr. Lou Bridges, chief of rheumatology at the Hospital for Special Surgery and NewYork-Presbyterian/Weill Cornell Medical Center, expressed cautious optimism. 'It's still early days. The proof will be in the pudding,' he said. 'I'm hoping they are correct, and this is a revolutionary new way to treat RA without drugs and without side effects. But I've heard this story before.' [With TOI inputs]
Time of India
13 hours ago
- Time of India
How a one-minute jolt can offer hope to those with auto-immune disease
The US Food and Drug Administration (FDA) approved a medical device recently that offers new hope to patients incapacitated by rheumatoid arthritis (RA), a chronic condition often resistant to treatment and usually managed with medications. The device represents a radical departure from standard care, tapping the power of the brain and nervous system to tamp down the uncontrolled inflammation that leads to the debilitating autoimmune disease. The SetPoint System is an inch-long device surgically implanted into the neck, where it sits in a pod wrapped around the vagus nerve, which some scientists believe is the longest nerve in the body. The device electrically stimulates the nerve for one minute each day. The stimulation can turn off crippling inflammation and 'reset' the immune system, research has shown. Most drugs used to treat rheumatoid arthritis suppress the immune system, leaving patients vulnerable to serious infections. On a recent episode of the American College of Rheumatology podcast, the SetPoint implant was described as a 'true paradigm shift' in treatment of the disease, which until now has relied almost entirely on an evolving set of pharmaceutical interventions, from gold salts to biologics. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo The FDA designated the implant as a breakthrough last year to expedite its development and approval. It represents an early test of the promise of so-called bioelectronic medicine to modulate inflammation, which plays a key role in diseases including diabetes, heart disease and cancer. Clinical trials are already underway testing vagus nerve stimulation to manage inflammatory bowel disease in children, lupus and other conditions. Trials for patients with multiple sclerosis and Crohn's disease are also planned. In a yearlong randomised controlled trial of 242 patients that included a sham-treatment arm, over half of the participants using the SetPoint implant alone achieved remission or saw their disease recede. Measures of joint pain and swelling fell by 60% and 63% respectively. The device's long-term effectiveness and safety outside a clinical trial are not yet known. The FDA required post-marketing monitoring of patients and adverse events as part of the approval. Surgery involving implants can lead to serious infections resistant to antibiotics, experts noted. For Dawn Steiner, 58, a speech pathologist, who participated in the clinical trial, the implant has been a game changer. She was diagnosed with rheumatoid arthritis 15 years ago and has tried eight different biologic agents since then. 'Before the implant, the doctor would ask where I was in terms of pain on a scale of one to 10, and I would say I was living a six or seven,' she said. 'Now I'm about a two.' The SetPoint device is the product of decades of research spearheaded by Dr Kevin J Tracey, a neurosurgeon who is president and chief executive of the Feinstein Institutes for Medical Research at Northwell Health. Tracey co-founded SetPoint Medical, but now serves as an adviser. He describes the vagus nerve, which originates in the brain and travels to virtually all the organs of the body, as an 'on-off switch' for an overactive immune system. 'The brain can turn off inflammation as long as the vagus nerve is intact,' he said. 'It's like a brake system in your car.' Dr David Chernoff, chief medical officer of SetPoint Medical, said, 'Drugs find a pathway that contributes to damaging joints in RA patients and try to block it. What we're doing is completely different. We're re-educating the immune system through the brain to behave differently,' he added. As a result, he said, 'we're not blocking the ability to fight off infection.' The body needs some level of inflammation, Tracey said, to help heal wounds, fight infections and promote tissue repair. The price has not been disclosed, but a spokeswoman said it was designed to last for 10 years and would be less expensive than a year's worth of some rheumatoid arthritis drugs, which can be quite costly. One key question is whether the implant's effectiveness will wane over time, said Dr Lou Bridges, chief of the division of rheumatology at the Hospital for Special Surgery and NewYork-Presbyterian/Weill Cornell Medical Center. 'It's still early days. The proof will be in the pudding,' he said. 'I'm hoping they are correct, and this is a revolutionary new way to treat RA without drugs and without side effects. But I've heard this story before. ' nyt news service By: Dr David Chernoff, CMO, SetPoint Medical
Mint
18 hours ago
- Mint
Soap recall: Contaminated products by DermaRite may cause deadly infections, all you need to know
A major soap recall is happening across America over deadly infection risks. DermaRite Industries pulled four types of antiseptic and antimicrobial soaps after finding dangerous bacteria in them. The products could cause 'life-threatening sepsis', a severe body-wide infection, especially when used on open wounds. Though no illnesses are reported yet, the company warns people to stop using these soaps immediately. The problem bacteria is called Burkholderia cepacia complex (Bcc), which lives in soil and water and resists many antibiotics. These medical soaps were sold nationwide and in Puerto Rico, often used in hospitals, nursing homes, and homes for wound care. Health officials say destroying the products is crucial to prevent potential tragedies. The hidden danger targets people with health challenges most. Healthy users might only get skin infections from the contaminated soaps, but immunocompromised people could develop deadly bloodstream infections. Burkholderia cepacia is especially risky for those with cystic fibrosis, lung disease, cancer, or recent surgeries. Symptoms range from nothing to fever, coughing up blood, or severe pneumonia. The FDA explains these bacteria spread easily through contaminated water or products. DermaRite hasn't revealed how the bacteria got into their soaps, but testing confirmed the contamination. Customers should watch for breathing problems or unusual fatigue after using these products. Experts note this recall highlights ongoing quality control issues in medical soap manufacturing. DermaKleen: Antiseptic lotion soap with Vitamin E DermaSarra: Itch-relief soap for irritated skin KleenFoam: Antibacterial foam for handwashing after diaper changes or caring for sick people PeriGiene: Perineal cleanser for sensitive private areas All were sold in plastic bottles online and through medical suppliers. The soaps were meant to protect vulnerable people but now pose serious risks. DermaRite urges businesses and households to check storage areas immediately. Don't donate or resell these products – the company advises destroying them using safety protocols like autoclaving or chemical treatment. Photos of the recalled items are on the FDA's website to help identification. Stop using all recalled products immediately Destroy them following your facility's hazardous material rules Contact DermaRite at (973) 569-9000 x104 or Report any health reactions to the FDA's MedWatch program If you used these soaps on wounds and feel sick, see a doctor right away. Mention the soap recall since Burkholderia infections need specific antibiotics. For extra protection, switch to alternative antiseptics like chlorhexidine-based products while avoiding recalled items. The FDA continues investigating how widespread the contamination is.
